Delivery Order SPE2DR25D2104-SPE2DR26F3PDU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,665.21 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 30, 2025, with an ultimate completion date of October 31, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $4,468 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of September 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,144.64 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,709.92 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,597.12 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 24, 2025. This is a firm fixed-price, non-set-aside delivery order issued to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...
- The Defense Logistics Agency awarded a $2,836.28 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $1,620.37 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors, with a completion deadline of July 21, 2025. This is a firm fixed price, non-set-aside contract executed on July 18, 2025, with performance at the company's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global...
- The Defense Logistics Agency awarded a $2,234 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.29 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of June 9, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor for this order, which will be performed at their corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,866.84 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 19, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PDUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,706.68 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, with a completion date of November 17, 2025. This is a firm fixed-price, non-set-aside contract issued on November 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company holds significant federal contract capacity through its DLA prime vendor agreement, which enables it to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This contract award for continuous glucose monitoring sensors supports the medical supply needs of the Department of Defense's healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/14/25 |